Apatinib in combination with docetaxel and S-1 chemotherapy as first-line treatment for metastatic gastric cancer.
- DOI
- 10.1002/ijc.70351
- Published
- 2026 Jun 1
- Container
- International journal of cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/ijc.70351,
title = {Apatinib in combination with docetaxel and S-1 chemotherapy as first-line treatment for metastatic gastric cancer.},
author = {Xia L and Gao Y and Yang L and Jiang H and Gong J and Wang Q and Wu H and Wang Y and Xu H and Wang W and He L and Chen W and Gong W and Yu X and Peng J and Dai J and Zhou F},
year = {2026},
journal = {International journal of cancer},
doi = {10.1002/ijc.70351},
url = {https://doi.org/10.1002/ijc.70351}
}RIS
TY - JOUR TI - Apatinib in combination with docetaxel and S-1 chemotherapy as first-line treatment for metastatic gastric cancer. AU - Xia L AU - Gao Y AU - Yang L AU - Jiang H AU - Gong J AU - Wang Q AU - Wu H AU - Wang Y AU - Xu H AU - Wang W AU - He L AU - Chen W AU - Gong W AU - Yu X AU - Peng J AU - Dai J AU - Zhou F PY - 2026 JO - International journal of cancer DO - 10.1002/ijc.70351 UR - https://doi.org/10.1002/ijc.70351 ER -
APA
L, X., Y, G., L, Y., H, J., J, G., Q, W., H, W., Y, W., H, X., W, W., L, H., W, C., W, G., X, Y., J, P., J, D., & F, Z. (2026). Apatinib in combination with docetaxel and S-1 chemotherapy as first-line treatment for metastatic gastric cancer.. International journal of cancer. https://doi.org/10.1002/ijc.70351
Source records
- pubmed · retrieved 2026-09-26T22:29:41.367Z